Biochemical markers for diagnosis of diseases and follow up

Slides:



Advertisements
Similar presentations
Biochemical Markers for Diagnosis of Myocardial Infarction.
Advertisements

1 Lecture | Dr. Usman Ghani
Liver Function Tests (LFTs)
1 CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FOUR Dr. Essam H. Aljiffri.
Enzymes in Body Fluids Lecture outline
Lecture 4. Special chemistry Definition Special Chemistry is a subsection of the Chemistry Laboratory of the Division of Clinical Pathology. This includes.
(clinical biochemistry of enzymes)
OnSite Troponin I Rapid Test. Cardiac markers are biomarkers measured to evaluate heart function.biomarkers They are often discussed in the context of.
By : dr. samer zahran. Key words myocardium : heart muscle coronary arteries : three major blood vessels supplying blood and oxygen to the heart muscles.
By Dr. Abdelaty Shawky Assistant Professor of Pathology
Enzymes in Clinical Diagnosis
Enzymes Dr. Noha Soliman.
Alanine Transaminase.
Liver function tests Lecture 3.
By: H.Baniamerian Kermanshah university of medical science.
Biochemical Markers of Myocardial Infarction
Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.
Tumor markers Present; by Dr. Andalib Isfahan Medical School
Biochemical markers in disease diagnosis
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Tumormarkers.
Tumor Markers.
Enzymes Biochemistry (BMS) L.Noha Soliman.
Blood Studies Liver function test (LFT) Group of biochemical tests Group of biochemical tests Uses of liver function test (LFTs) Differential diagnosis.
Enzyme Clinical Application
Biochemical Markers for Diagnosis of Myocardial Infarction Cardiovascular Block Medical Biochemistry Course Dr. Reem M. Sallam, MD, PhD.
Biochemical Investigations In Heart Disaeses
Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.
Ischaemic Heart Disease CASE A. CASE A: Mr HA, aged 60 years, was brought in to A&E complaining of chest pain, nausea and a suspected AMI.
Dr. Aya M. Serry Renal Failure Renal failure is defined as a significant loss of renal function in both kidneys to the point where less than 10.
Biochemical markers for diagnosis and follow up of disease
Biochemical Markers of Myocardial Infarction
Welcome Advanced Clinical Chemistry BISC Dr Atef Masad PhD Biomedicine Uinited Kingdom Advanced Clinical Chemistry BISC 6360.
Biochemical Markers for Diagnosis of Myocardial Infarction
Lab 3 ALT and AST Daheeya AlEnazi.
Lab # 2 Liver Function Tests (LFTs) ALT&AST T.A. Bahiya M. Osrah.
Unit 6: Tumor markers. Introduction… Cancer is the second leading cause of death in North America, accounting for > 2.7 million deaths annually Although.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Serelaxin on Cardiac, Renal, and Hepatic.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Serelaxin on Cardiac, Renal, and Hepatic.
CLINICAL APPLICATION OF UREA MEASUREMENTS METABOLIC ASPECTS OF KIDNEY METABOLISM.
Troponin By Julie Moore C Dt204/2.
Clinical usage of enzymes
Common pitfall in Oncology Luangyot Thongthieang, MD MEDICAL ONCOLOGY UNIT INTERNAL MEDICINE, KHONKAEN HOSPITAL.
How Is Chemotherapy Used to Treat Cancer?
LIVER FUNCTION TESTS
Liver Function Tests (LFTs)
SURGICAL ONCOLOGY AND TUMOR MARKERS
Liver Function Tests (LFTs)
Enzymes in the Diagnosis of Pathology
Biochemical Investigations In Heart Disaeses
Biochemical Markers of Myocardial Infarction
Biochemistry MI Biomarkers Important. Extra Information.
– Color Index: Important. Extra Information. Doctors slides.
Kidney Function Tests Dr Rana hasanato
Intrahepatic cholestasis of pregnancy
Biochemical Markers of Myocardial Infarction
Muthana Al-Shemeri Lab. Assistants, Mr Jamal Abdulfattah Mrs Ferdws
Interpretation Of LAB Data
biochemical markers for diagnosis and follow up of diseases
Biochemical markers for diagnosis of diseases and follow up
Biomarkers of ovarian cancer and cysts
Biomarkers of ovarian cancer and cysts
Tumor Marker Tests.
Presented By: Sally Saad Mandour Esawy
Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome.
Cardiac enzymes and cardiac proteins
Daheeya AlEnazi Cromatest Kit
Bilirubin & Amylase Lab. 10.
Biochemical Markers of Myocardial Infarction
Cardiac profile test.
Determination of plasma enzymes
Presentation transcript:

Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department Director of laboratories and blood bank

Lecture objectives: Upon completion of this lecture, the students should be able to: Define biomarkers and its criteria Recognize different types of biochemical markers Demonstrate the clinical applications of biomarkers in diagnosis of various diseases

What is a biomarker? A biological molecule found in blood, other body fluids, or tissues that indicates a normal or abnormal process such as a disease or a condition

Most common body fluids for the measurement of biomarkers are: Blood Urine Biomarkers are either: Plasma-specific Tissue-specific

Plasma-specific biomarkers: Normally present in plasma Perform their functions in blood High level of activity in plasma than in tissue cells

Tissue-specific biomarkers: Present inside the cell A low concentration can be detected in plasma due to cellular turnover If higher concentration is detected in plasma, it indicates cell damage.

Cell damage can be due to: 1- Tissue inflammation, example: ALT* in liver disease (e.g. acute hepatitis) Amylase in acute pancreatitis 2- Ischemia  hypoxia  infarction  ↑ plasma [Troponin] in myocardial infarction ALT*: alanine aminotransferase

diagnosis and prognosis: Diagnosis: Identification of a disease from its signs and symptoms Prognosis: The future outcome of a disease

Criteria of a good biomarker assay: A good biomarker assay should be: Sensitive: Sensitivity is the Ability of an assay to detect small quantities of a marker Specific: Specificity is the ability of an assay to detect only the marker of interest Robust to produce fast results

Examples of biomarkers: Enzymes Hormones Proteins

Enzymes as biomarkers: Examples include: Amylase, Lipase Alanine aminotransferase (ALT) Aspartate aminotransferase (AST)

Amylase: Elevated serum amylase level is a diagnostic indicator of acute pancreatitis Amylase level greater than 10 times the upper limit indicates acute pancreatitis The test has low specificity because elevated amylase level is also present in other diseases Amylase appears in the serum within 2-12 hours after abdominal pain, and returns to normal in 3-5 days

Lipase: Serum lipase has higher specificity than serum amylase (elevated only in acute pancreatitis) It appears in plasma within 4-8 hours and remains for 8-14 days

Case: A GP was called to see a 21-year-old female student who had been complaining a flu-like illness for two days, with symptoms of fever, vomiting and abdominal tenderness in the right upper quadrant. On examination she was jaundiced, moreover; the liver was enlarged and tender. A blood was taken for liver function tests which showed elevated ALT (alanine aminotransferase) and AST (aspartate aminotransferase) What is the most likely diagnosis? Acute Hepatitis

Aspartate aminotransferase (AST) Alanine aminotransferase (ALT): Produced by: heart, liver, skeletal muscle, kidney, erythrocytes liver Elevated in: Liver disease, heart disease, skeletal muscle disease, hemolysis Liver disease

Proteins as biomarkers: a-Fetoprotein Prostate Specific Antigen (PSA) Cystatin C B-type Natriuretic Peptide (BNP)

a-Fetoprotein: It is produced by the fetal liver, and falls until term  in newborn babies a-fetoprotein levels are very low It remains low under normal conditions. High conc. are observed in: hepatocellular carcinomas (hepatoma) testicular carcinomas GI tract carcinomas It is a non specific marker

Prostate Specific Antigen (PSA): Produced by prostate gland PSA level is used as a tumor marker to aid diagnosis and for monitoring in patients with prostatic cancer. High serum levels are also observed in: Benign prostatic hyperplasia (BPH) Prostatic inflammation/infection

Cystatin C: A cysteine protease inhibitor mainly produced by all nucleated cells of the body Useful biomarker for measuring glomerular filtration rate (GFR) in assessing kidney function Unlike creatinine, its serum conc. is independent of gender, age or muscle mass High levels of serum cystatin C indicates early renal disease Clinically used as a marker for: detecting early kidney disease monitoring kidney transplantation

B-type natriuretic peptide (BNP) A peptide secreted mainly in the cardiac ventricles in response to cardiac expansion and pressure overload High serum levels are observed in congestive heart failure It can be used to differentiate patients whose symptoms are due to heart failure from those whose symptoms are due to other causes such as pulmonary disease.

Hormones as biomarkers: Anti-Mullerian hormone (AMH): In females it is produced by ovaries Appears to be a best marker for estimating egg cell reserve in the ovaries(ovarian reserve testing) only growing follicles produce AMH Plasma AMH levels strongly correlate with number of growing follicles g with infertility

Anti-Mullerian hormone (AMH) High levels in women with Polycystic ovarian syndrome (PCOS) Low levels in women with ovarian dysfunction

Take home message: Biochemical markers are essential accurate and non- invasive laboratory tools offering the treating physicians fast means for better management. They could be proteins, enzymes, or hormones. Recent development in medicine provides new biomarkers